MorphoSys and Xencor Provide Update on Phase 1/2a Trial in CLL/SLL for MOR208

News   Oct 08, 2013

 
MorphoSys and Xencor Provide Update on Phase 1/2a Trial in CLL/SLL for MOR208
 
 
 
FURTHER INFORMATION
 

Like what you just read? You can find similar content on the communities below.

Cancer Research Cell Science Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE
 
 

Comments | 0 ADD COMMENT